| 0 |
Echinocandin Antifungal [EPC] |
44 |
0.0054 |
| 1 |
Lipid-based Polyene Antifungal [EPC] |
65 |
0.0051 |
| 2 |
Monobactam Antibacterial [EPC] |
8 |
0.0029 |
| 3 |
Antimetabolite Immunosuppressant [EPC] |
52 |
0.0024 |
| 4 |
Polyene Antifungal [EPC] |
81 |
0.0020 |
| 5 |
Penem Antibacterial [EPC] |
51 |
0.0015 |
| 6 |
Interleukin-5 Antagonist [EPC] |
1 |
0.0015 |
| 7 |
Interleukin-1 Receptor Antagonist [EPC] |
22 |
0.0013 |
| 8 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
23 |
0.0010 |
| 9 |
Lipopeptide Antibacterial [EPC] |
9 |
0.0009 |
| 10 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
12 |
0.0009 |
| 11 |
Tetracycline-class Antibacterial [EPC] |
7 |
0.0009 |
| 12 |
Azole Antifungal [EPC] |
134 |
0.0009 |
| 13 |
Glycopeptide Antibacterial [EPC] |
54 |
0.0008 |
| 14 |
Antimalarial [EPC] |
7 |
0.0007 |
| 15 |
Antiprotozoal [EPC] |
7 |
0.0007 |
| 16 |
Carnitine Analog [EPC] |
2 |
0.0005 |
| 17 |
Fluoroquinolone Antibacterial [EPC] |
57 |
0.0004 |
| 18 |
Antimycobacterial [EPC] |
10 |
0.0004 |
| 19 |
Anthelmintic [EPC] |
1 |
0.0003 |
| 20 |
Topoisomerase Inhibitor [EPC] |
26 |
0.0003 |
| 21 |
Oxazolidinone Antibacterial [EPC] |
10 |
0.0003 |
| 22 |
Alkylating Drug [EPC] |
75 |
0.0003 |
| 23 |
Interleukin-6 Receptor Antagonist [EPC] |
41 |
0.0003 |
| 24 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
33 |
0.0003 |
| 25 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
33 |
0.0003 |
| 26 |
CTLA-4-directed Blocking Antibody [EPC] |
13 |
0.0003 |
| 27 |
alpha-1 Adrenergic Agonist [EPC] |
1 |
0.0002 |
| 28 |
BCL-2 Inhibitor [EPC] |
14 |
0.0002 |
| 29 |
CD20-directed Cytolytic Antibody [EPC] |
70 |
0.0002 |
| 30 |
Corticosteroid [EPC] |
262 |
0.0002 |
| 31 |
Programmed Death Ligand-1 Blocker [EPC] |
4 |
0.0002 |
| 32 |
Nucleoside Analog Antiviral [EPC] |
14 |
0.0002 |
| 33 |
Janus Kinase Inhibitor [EPC] |
25 |
0.0002 |
| 34 |
Alkaloid [EPC] |
4 |
0.0002 |
| 35 |
Asparagine-specific Enzyme [EPC] |
2 |
0.0001 |
| 36 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
14 |
0.0001 |
| 37 |
Human Immunoglobulin G [EPC] |
3 |
0.0001 |
| 38 |
Thrombopoietin Receptor Agonist [EPC] |
2 |
0.0001 |
| 39 |
Catecholamine [EPC] |
10 |
0.0001 |
| 40 |
Vitamin K [EPC] |
1 |
0.0001 |
| 41 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
15 |
0.0001 |
| 42 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
10 |
0.0001 |
| 43 |
Nucleoside Metabolic Inhibitor [EPC] |
24 |
0.0001 |
| 44 |
Folate Analog Metabolic Inhibitor [EPC] |
35 |
0.0001 |
| 45 |
Kinase Inhibitor [EPC] |
36 |
0.0001 |
| 46 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 47 |
Tetracycline-class Drug [EPC] |
3 |
0.0000 |
| 48 |
Leukocyte Growth Factor [EPC] |
6 |
0.0000 |
| 49 |
Proteasome Inhibitor [EPC] |
4 |
0.0000 |
| 50 |
Platelet Aggregation Inhibitor [EPC] |
18 |
0.0000 |
| 51 |
Rifamycin Antibacterial [EPC] |
1 |
0.0000 |
| 52 |
Vitamin D [EPC] |
8 |
0.0000 |
| 53 |
Proton Pump Inhibitor [EPC] |
15 |
0.0000 |
| 54 |
Platinum-based Drug [EPC] |
7 |
0.0000 |
| 55 |
Angiotensin 2 Receptor Blocker [EPC] |
8 |
0.0000 |
| 56 |
Vitamin B12 [EPC] |
8 |
0.0000 |
| 57 |
General Anesthetic [EPC] |
1 |
0.0000 |
| 58 |
Protease Inhibitor [EPC] |
1 |
0.0000 |
| 59 |
Aminoglycoside Antibacterial [EPC] |
1 |
0.0000 |
| 60 |
Pyrimidine Synthesis Inhibitor [EPC] |
1 |
0.0000 |
| 61 |
Osmotic Laxative [EPC] |
6 |
0.0000 |
| 62 |
Aminosalicylate [EPC] |
2 |
0.0000 |
| 63 |
Loop Diuretic [EPC] |
9 |
0.0000 |
| 64 |
Vitamin C [EPC] |
8 |
0.0000 |
| 65 |
Tumor Necrosis Factor Blocker [EPC] |
18 |
0.0000 |
| 66 |
Cytochrome P450 3A Inhibitor [EPC] |
1 |
0.0000 |
| 67 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
20 |
0.0000 |
| 68 |
Nitroimidazole Antimicrobial [EPC] |
1 |
0.0000 |
| 69 |
Benzodiazepine [EPC] |
6 |
0.0000 |
| 70 |
Thalidomide Analog [EPC] |
4 |
0.0000 |
| 71 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 72 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 73 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 74 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |